BR9810026A - Vaccine composition, use of a helicobacter pylori polypeptide flge or a modified form thereof, use of the same, vaccine composition to induce a protective immune response to helicobacter pylori infection, in vitro diagnostic process of helicobacter pylori infection, kit method for detecting helicobacter pylori infection in a mammal including man, and process for eliciting a protective immune response against helicobacter pylori infection in a mammal - Google Patents
Vaccine composition, use of a helicobacter pylori polypeptide flge or a modified form thereof, use of the same, vaccine composition to induce a protective immune response to helicobacter pylori infection, in vitro diagnostic process of helicobacter pylori infection, kit method for detecting helicobacter pylori infection in a mammal including man, and process for eliciting a protective immune response against helicobacter pylori infection in a mammalInfo
- Publication number
- BR9810026A BR9810026A BR9810026-2A BR9810026A BR9810026A BR 9810026 A BR9810026 A BR 9810026A BR 9810026 A BR9810026 A BR 9810026A BR 9810026 A BR9810026 A BR 9810026A
- Authority
- BR
- Brazil
- Prior art keywords
- helicobacter pylori
- pylori infection
- immune response
- protective immune
- vaccine composition
- Prior art date
Links
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 5
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000001681 protective effect Effects 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000590002 Helicobacter pylori Species 0.000 title abstract 3
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 3
- 238000000338 in vitro Methods 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 2
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO DE VACINA, USO DE UM POLIPEPTìDEO FLGE DE HELICOBACTER PYLORI, OU UMA FORMA MODIFICADA DO MESMO, PROCESSO DE DIAGNOSE IN VITRO DA INFECçãO DE HELICOBACTER PYLORI, KIT DE DIAGNOSE PARA USO NESSE PROCESSO, E, PROCESSO PARA INDUZIR EM UM MAMìFERO UMA RESPOSTA IMUNE PROTETORA CONTRA A INFECçãO PELO HELICOBACTER PYLORI". A presente invenção diz respeito a polipeptídeos e composições de vacina para induzir uma resposta imune protetora à infecção pelo Helicobacter pylori. A invenção, além disso, diz respeito ao uso de polipeptídeos de Helicobacter pylori na fabricação de composições para o tratamento e profilaxia da infecção pelo Helicobacter pylori."VACCINE COMPOSITION, USE OF A FLGE POLYPEPTIDE OF HELICOBACTER PYLORI, OR A MODIFIED FORM OF THE SAME, IN VITRO DIAGNOSIS PROCESS OF THE HELICOBACTER PYLORI INFECTION, DIAGNOSIS KIT FOR USE IN THIS PROCESS, A PROCESS IN A PROCESS, AND A PROCESS IN A PROCESS, PROTECTIVE IMMUNE AGAINST HELICOBACTER PYLORI INFECTION ". The present invention relates to polypeptides and vaccine compositions to induce a protective immune response to Helicobacter pylori infection. The invention furthermore relates to the use of Helicobacter pylori polypeptides in the manufacture of compositions for the treatment and prophylaxis of Helicobacter pylori infection.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (en) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
| PCT/SE1998/001093 WO1998056816A1 (en) | 1997-06-12 | 1998-06-08 | VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9810026A true BR9810026A (en) | 2000-09-19 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9810026-2A BR9810026A (en) | 1997-06-12 | 1998-06-08 | Vaccine composition, use of a helicobacter pylori polypeptide flge or a modified form thereof, use of the same, vaccine composition to induce a protective immune response to helicobacter pylori infection, in vitro diagnostic process of helicobacter pylori infection, kit method for detecting helicobacter pylori infection in a mammal including man, and process for eliciting a protective immune response against helicobacter pylori infection in a mammal |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (en) |
| JP (1) | JP2002507118A (en) |
| KR (1) | KR20010013699A (en) |
| CN (1) | CN1259960A (en) |
| AR (1) | AR012896A1 (en) |
| AU (1) | AU8048798A (en) |
| BR (1) | BR9810026A (en) |
| CA (1) | CA2293293A1 (en) |
| EE (1) | EE9900566A (en) |
| HU (1) | HUP0003164A3 (en) |
| ID (1) | ID23052A (en) |
| IL (1) | IL133144A0 (en) |
| IS (1) | IS5288A (en) |
| NO (1) | NO996132L (en) |
| NZ (1) | NZ501427A (en) |
| PL (1) | PL337503A1 (en) |
| SE (1) | SE9702242D0 (en) |
| SK (1) | SK173099A3 (en) |
| TR (1) | TR199903060T2 (en) |
| WO (1) | WO1998056816A1 (en) |
| ZA (1) | ZA984696B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (en) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa |
| CN113425717B (en) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof |
| CN116535472B (en) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof |
| CN118105473A (en) * | 2024-04-30 | 2024-05-31 | 成都欧林生物科技股份有限公司 | Oral immunogenic composition for preventing or treating Hp infection and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (en) * | 1995-06-01 | 1998-07-08 | Astra Ab | BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/en unknown
-
1998
- 1998-06-01 AR ARP980102558A patent/AR012896A1/en unknown
- 1998-06-01 ZA ZA984696A patent/ZA984696B/en unknown
- 1998-06-08 PL PL98337503A patent/PL337503A1/en unknown
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/en unknown
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 SK SK1730-99A patent/SK173099A3/en unknown
- 1998-06-08 IL IL13314498A patent/IL133144A0/en unknown
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/en not_active Application Discontinuation
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/en unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/en active Pending
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/en not_active IP Right Cessation
- 1998-06-08 NZ NZ501427A patent/NZ501427A/en unknown
- 1998-06-08 EE EEP199900566A patent/EE9900566A/en unknown
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 CN CN98806101A patent/CN1259960A/en active Pending
- 1998-06-08 ID IDW991542A patent/ID23052A/en unknown
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/en unknown
- 1999-12-10 NO NO996132A patent/NO996132L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID23052A (en) | 2000-01-20 |
| IL133144A0 (en) | 2001-03-19 |
| CN1259960A (en) | 2000-07-12 |
| WO1998056816A1 (en) | 1998-12-17 |
| NZ501427A (en) | 2000-09-29 |
| SK173099A3 (en) | 2000-06-12 |
| IS5288A (en) | 1999-12-08 |
| KR20010013699A (en) | 2001-02-26 |
| AU8048798A (en) | 1998-12-30 |
| NO996132L (en) | 2000-01-28 |
| TR199903060T2 (en) | 2000-09-21 |
| AR012896A1 (en) | 2000-11-22 |
| ZA984696B (en) | 1999-01-04 |
| EE9900566A (en) | 2000-06-15 |
| HUP0003164A2 (en) | 2000-12-28 |
| NO996132D0 (en) | 1999-12-10 |
| SE9702242D0 (en) | 1997-06-12 |
| JP2002507118A (en) | 2002-03-05 |
| CA2293293A1 (en) | 1998-12-17 |
| PL337503A1 (en) | 2000-08-28 |
| EP1009764A1 (en) | 2000-06-21 |
| HUP0003164A3 (en) | 2001-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zahradnik et al. | In vitro enamel demineralization by Streptococcus mutans in the presence of salivary pellicles | |
| ATE247985T1 (en) | INTRODUCTION OF A THIOL GROUP INTO PROTEINS FOR RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY BASED ON RADIONUCLIDES | |
| CY1109024T1 (en) | STREPTOCOCCUS PNEUMONIAE PROTEINS AND IMMUNOLABLE SHAPE FOR VACCINATION | |
| DE69637914D1 (en) | VEGETABLE AGAINST VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTIVE DISEASES IN PIGS | |
| MX9203278A (en) | SUSTAINED RELEASE PILL INCLUDING LORATADINE, IBUPROFEN AND PSEUDOEFEDRINE. | |
| BR9909472A (en) | Purified polypeptide, process to prevent tuberculosis, and pharmaceutical composition | |
| EP0683234A4 (en) | ANTIBODY AGAINST -g(b)-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF. | |
| ES8801318A1 (en) | Gag antigen and its use for the detection of lav infection and in immunogenic compositions | |
| BR9916020A (en) | Compounds and methods for the treatment and diagnosis of chlamydia infection | |
| BR0213540A (en) | Compounds, method for treating a patient's illness or disorder and a pharmaceutical composition comprising them | |
| DK104590D0 (en) | HIV PEPTIDES, ARTIFICIAL HIV ANTIGEN AND IMMUNOASSAY | |
| NO902280D0 (en) | NEW POROE'S PHARMACEUTICAL FORM AND MANUFACTURING THEREOF. | |
| Ito et al. | ELISA and immunoblot using purified glycoproteins for serodiagnosis of cysticercosisin pigs naturally infected with Taenia solium | |
| UA42040C2 (en) | Polypeptide, method for diagnostics of insulin-dependent diabetes mellitus (IDDM), which has been developed or is developing (variants), kit for diagnostics of (variants), preparation for prevention of treatment of IDDM, pharmaceutical composition for prophylaxis or treatment of IDDM | |
| NO996514L (en) | Surface antigens and proteins useful in compositions for diagnosis and prevention of Lyme disease | |
| BR9810026A (en) | Vaccine composition, use of a helicobacter pylori polypeptide flge or a modified form thereof, use of the same, vaccine composition to induce a protective immune response to helicobacter pylori infection, in vitro diagnostic process of helicobacter pylori infection, kit method for detecting helicobacter pylori infection in a mammal including man, and process for eliciting a protective immune response against helicobacter pylori infection in a mammal | |
| BR0207018A (en) | Modified leptin with reduced immunogenicity | |
| DE3879085D1 (en) | SNRNP-A-ANTIGEN AND FRAGMENTS THEREOF. | |
| Yamaguchi et al. | Preparation and characterization of an Actinomyces naeslundii aggregation factor that mediates coaggregation with Porphyromonas gingivalis | |
| ES2057572T3 (en) | RECOGNITION AGENTS. | |
| BR9916549A (en) | Pharmaceutical composition, vaccine, protein, and, method for the prevention or treatment of leishmaniasis in a human or animal. | |
| BR0207905A (en) | Modified protamine with reduced immunogenicity | |
| DE69002946T2 (en) | MEDICINE PREPARATION CONTAINING PARACETAMOL. | |
| DK76191D0 (en) | FILAMENTOEST HAEMAGGLUTININ FROM B.PERTUSSIS | |
| NO900920L (en) | APROTININ HOMOLOGIST AND PROCEDURE FOR THE PREPARATION OF APROTININ AND APROTININ HOMOLOGIST IN GYER. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007. |